GeNext Genomics Pvt Ltd

One-stop solution for your antibody and protein needs.

[GeNext Genomics Pvt Ltd @GeNextGenomics]

GeNext Genomics supports purification from serum preparation and clarification through precipitation, dialysis, affinity purification, and quality assessment. DM: [email protected] | https://t.co/7DpPG44oPP

[GeNext Genomics Pvt Ltd @GeNextGenomics]

Blog Post: Billions of antibody candidates. 1 target. A handful of screening rounds to find the winner. That's the promise of phage display, a technology that's reshaped how therapeutic antibodies get discovered. Read here: https://t.co/jph4p73svm
DM: [email protected]

[GeNext Genomics Pvt Ltd @GeNextGenomics]

GNG supports the polyclonal ab purification from serum prep. & clarification | Ammonium sulphate precipitation | Dialysis | Protein A, G or antigen-specific affinity purification | SDS-PAGE, ELISA & application-specific QC. DM: [email protected] | https://t.co/7DpPG44oPP

[GeNext Genomics Pvt Ltd @GeNextGenomics]

GeNext Genomics supports CHO cell line development from vector design and transfection through stable pool generation, single-cell cloning, clone screening, ranking, and scale-up. DM: [email protected] | https://t.co/7DpPG44WFn

[GeNext Genomics Pvt Ltd @GeNextGenomics]

Blog Post: Not every antibody has to start from scratch. When a donor has already mounted a strong immune response through infection, vaccination, or immunisation, their B cells carry antibodies. Read more about it here: https://t.co/eQPG2ra7g3. DM: [email protected]

[GeNext Genomics Pvt Ltd @GeNextGenomics]

GNG supports CHO stable cell line development across the critical stages: Expression vector design & transfection | Stable pool generation | Single-cell cloning | Clone screening & ranking | Scale-up & top-clone selection. DM: [email protected] | https://t.co/7DpPG44oPP

[GeNext Genomics Pvt Ltd @GeNextGenomics]

GeNext Genomics uses its HIND Human Immune Naïve phage display platform to support high-affinity monoclonal antibody discovery across applications requiring different antibody formats. DM: [email protected] | https://t.co/7DpPG44WFn

[GeNext Genomics Pvt Ltd @GeNextGenomics]

Speed and precision define modern biotech.
At GeNext Genomics, our automated high-throughput screening platforms help you test faster, analyse smarter, and scale discoveries with confidence. DM: [email protected] | https://t.co/7DpPG44WFn

[GeNext Genomics Pvt Ltd @GeNextGenomics]

GeNext Genomics leverages its HIND Human Immune Naïve phage display platform to support high-affinity mab discovery and downstream development supporting scFv, Fab, and single-domain abs | Bispecific abs precursors.
DM: [email protected] | https://t.co/7DpPG44oPP

[GeNext Genomics Pvt Ltd @GeNextGenomics]

At GeNext Genomics, we engineer recombinant proteins that accelerate research, enable breakthroughs, and power the future of healthcare. From gene optimisation to vaccine development we deliver performance you can trust. DM: [email protected] | https://t.co/7DpPG44oPP

[GeNext Genomics Pvt Ltd @GeNextGenomics]

At GeNext Genomics, our hybridoma platform delivers monoclonal antibodies that are specific, stable, and scalable – designed for research, diagnostics, and therapeutic discovery. DM: [email protected] | https://t.co/7DpPG44oPP

[GeNext Genomics Pvt Ltd @GeNextGenomics]

With Biolayer Interferometry (BLI), GNG provides real-time, label-free interaction analysis to support antibody discovery, biosimilar development, and quality control workflows. DM: [email protected] | https://t.co/7DpPG44WFn

[GeNext Genomics Pvt Ltd @GeNextGenomics]

Blog Post: Monoclonal antibodies changed medicine. The next wave of therapeutic antibody formats is set to change it again. Bispecifics, antibody-drug conjugates, and emerging formats are pushing beyond what a single mAb can do. Read more about it here: https://t.co/7TyFm7RRWX

[GeNext Genomics Pvt Ltd @GeNextGenomics]

GNG offers end-to-end LFA for rapid & point-of-care diagnostics. From antibody pair validation, conjugation to strip assembly, optimisation, validation, & scaling, we deliver field-ready performance across diagnostic applications. DM: [email protected]

[GeNext Genomics Pvt Ltd @GeNextGenomics]

GNG supports antibody-drug immunomonitoring through CD32-mediated immune complex analysis, integrating therapeutic antibody engagement, anti-drug antibody detection, immune-complex quantification, assay development, and validation. DM: [email protected]

[GeNext Genomics Pvt Ltd @GeNextGenomics]

Designed for high sensitivity and specificity, our ELISA solutions support accurate biomarker detection across research, diagnostic, and complex biological sample applications. Visit: https://t.co/2rQ4vmSGNL | DM: [email protected]

[GeNext Genomics Pvt Ltd @GeNextGenomics]

At GNG, we combine in silico modelling with advanced mammalian expression to deliver higher yields, functional activity, and faster development cycles. DM: [email protected] | https://t.co/7DpPG44WFn

[GeNext Genomics Pvt Ltd @GeNextGenomics]

Whether you are navigating complex research applications or developing novel therapeutics, flexibility in format is critical. Accelerate your timelines with precision-engineered discovery. Visit: https://t.co/2CyQmiONKK | DM: [email protected]

[GeNext Genomics Pvt Ltd @GeNextGenomics]

GNG supports immunomonitoring through a CD32-mediated immune complex platform, connecting: Therapeutic ab engagement | Anti-drug ab detection | Immune-complex quantification | Protein design | Assay validation & tech transfer. DM: [email protected] | https://t.co/7DpPG44oPP

[GeNext Genomics Pvt Ltd @GeNextGenomics]

Whether you are advancing biosimilars or developing next-gen diagnostics, our data-driven approach ensures your antibodies perform exactly as needed and accelerate your timeline to market. Reach out to us! Contact: [email protected] | Visit https://t.co/7DpPG44WFn